 | Articles: Drug Trials |
Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV(TM)) Met its Primary Endpoint
Corporate News Releases, 08/12/08
First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
Corporate News Releases, 08/11/08
IMPAX Reports Positive Results in Phase III Trial with IPX056
Corporate News Releases, 08/11/08
 | | Sponsor |
Dynavax and Merck report positive results from Phase III hepatitis trial
Corporate News Releases, 08/08/08
Lexicon completes Phase I irritable bowel syndrome trial
PharmiWeb, 08/08/08
Tolerxs partner Genentech initiates Phase I monoclonal antibody trial
Corporate News Releases, 08/08/08
Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV) Met its Primary Endpoint
Merck & Co., 08/08/08
ARIAD Announces Start of Phase 2 Clinical Study of Oral Deforolimus in Patients with Advanced Endometrial Cancer
Ariad, 08/08/08
Genzyme and Isis Begin Second Phase 3 Trial of Mipomersen
Genzyme, 08/08/08
Xanodyne Achieves Positive Efficacy Results in Pivotal Phase 3 Studies of Proprietary Modified Release Oral Tranexamic Acid Product Candidate for Heavy Menstrual Bleeding
Corporate News Releases, 08/07/08
|
 Receive daily email updates on Drug Trials
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
|
